01-Mar-2021

Sterile Injectables Market Size Upsurges By 2027 with Massive Gains as US$ 673.8 Billion; Industry Affirmations By Top Competitors | Coherent Market Insights

The Global Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others), By Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous Systems Disorders, Infectious Disorders, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 357.4 Bn in 2018, and is expected to exhibit a CAGR of 7.3% over the forecast period (2019–2027).

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/201

An increasing number of product launches and approvals are major factors that are expected to drive the global sterile injectables market growth during the forecast period. For instance, in September 2018, Dr Reddy’s Laboratories Ltd launched Neostigmine Methylsulfate Injection in the U.S., a generic version of the Bloxiverz (Neostigmine Methylsulfate) injection. Moreover, in July 2016, Claris Lifescience Ltd., a sterile injectables company received the Abbreviated New Drug Application (ANDA) approval in U.S. for Tobramycin Injection USP, 80mg/2ml, and 1200mg/30ml multiple-dose vials. Increasing demand for sterile injectables has motivated manufacturers to expand their portfolio of sterile injectables by opening new manufacturing facilities.

For instance, in July 2019, Mapi Pharma Ltd., an integrated, late-stage clinical development biopharmaceutical company entered a lease agreement at the Har-Hotzvim Hi-Tech Park in Jerusalem for establishing a new sterile production plant for Glatiramer Acetate (GA) depot long action injectable.

Quick Buy – Sterile Injectables Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/201

Key players in the market are focused on adopting inorganic growth strategies such as acquisitions in order to expand their portfolio of sterile injectables. For instance, in July 2017, Baxter International Inc., a global medical product company, acquired Claris injectables Ltd., a wholly owned subsidiary of Claris Lifesciences Ltd, a global generic injectables pharmaceutical company. Through this acquisition, both Baxter and Claris Injectables will provide access to low-cost generic injectables which will help Baxter to meet the unmet needs of healthcare providers and patients around the world. Moreover, in July 2019, Civica Rx, a hospital-owned nonprofit generic drug company entered a five-year agreement with Hikma Pharmaceuticals to manufacture and supply 14 sterile injectables medications. These 14 sterile injectables include general injectables used by hospitals and in emergency care, or used in surgery, pain management, and to treat hypertension.

Browse 49 Market Data, Tables, and 46 Figures spread through 197 Pages and in-depth TOC on the Global Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others), By Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous Systems Disorders, Infectious Disorders, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2027

To know the latest trends and insights prevalent in the Sterile Injectables Market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/sterile-injectable-market-to-breach-us-540-billion-level-by-2024-as-pharma-giants-focus-on-capitalizing-on-lucrative-opportunities-in-emerging-economies-191

Key takeaways of the Global Sterile Injectables Market:

The global sterile injectables market is expected to exhibit a CAGR of 7.3% during the forecast period (2019–2027) owing to increasing product launches, product approvals and mergers and acquisitions of sterile injectable companies
Increasing demand for generic sterile injectables due to availability of treatment of chronic diseases is expected to drive the global sterile injectables market growth over the forecast period
High global prevalence of cancer, type 2 diabetes, cardiovascular disease, and infectious diseases such as tuberculosis and malaria are the major therapeutic applications for sterile injectables, which is expected to drive the market growth during the forecast period. For instance, according to the National Cancer Institute, in 2012, around 14.1 million new cases of cancer were reported and 8.2 million deaths due to cancer were recorded worldwide.
Some of the major players operating in the global sterile injectables market include Baxter Inc., AstraZeneca Plc., Merck & Co. Inc., Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., JHP Pharmaceuticals, Pfizer Inc., Fresenius Kabi Ag, CordenPharma, and Hikma Pharmaceuticals PLC.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Molecule Type
  - Market Snippet, By Drug Type
  - Market Snippet, By Therapeutic Application
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Pipeline Analysis
- Recent Product Approval/Launch
- Regulatory Scenario
- Reimbursement Scenario
- Mergers and Acquisitions, Collaborations & Partnerships
- PEST Analysis
- Porter’s Analysis
- Epidemiology
Global Sterile Injectables Market, By Molecule Type, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Large Molecules
- Small Molecules
Global Sterile Injectables Market, By Drug Type, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Monoclonal Antibodies (mAbs)
- Cytokines
- Insulin
- Peptide Hormones
- Vaccines
- Immunoglobulins
- Blood Factors
- Peptide Antibiotics
- Others
Global Sterile Injectables Market, By Therapeutic Application, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Cancer
- Metabolic Diseases
- Cardiovascular Diseases
- Central Nervous Systems Disorders
- Infectious Disorders
- Musculoskeletal Disorders
- Others
Global Sterile Injectables Market, By Route of Administration, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Subcutaneous (SC)
- Intravenous (IV)
- Intramuscular (IM)
- Others
Global Sterile Injectables Market, By Distribution Channel, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sterile Injectables Market, By Region, 2016 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, For Regions, 2019–2027
- North America
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region, 2017 – 2027 (US$ Mn)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region, 2017 – 2027 (US$ Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region, 2017 – 2027 (US$ Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region, 2017 – 2027 (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Africa
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region/Country, 2017 – 2027 (US$ Mn)
    - Central Africa
    - South Africa
    - North Africa
- Middle East
  - Market Size and Forecast, By Molecule Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Drug Type, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Therapeutic Application, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, Distribution Channel, 2017 – 2027 (US$ Mn)
  - Market Size and Forecast, By Region, 2017 – 2027 (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Company Profiles
  - Baxter International Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategy
  - AstraZeneca plc
  - Merck & Co., Inc
  - Novartis AG
  - Johnson & Johnson Services, Inc.
  - Gilead Sciences, Inc.
  - JHP Pharmaceuticals
  - Pfizer Inc.
  - Fresenius Kabi Ag
  - CordenPharma
  - Hikma Pharmaceuticals PLC.
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 01-Mar-2021